10mM in DMSO for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
GSK-3β inhibitor 3 is a potent, selective, irreversible and covalent inhibitor of Glycogen Synthase Kinase 3β (GSK-3β) , with an IC 50 of 6.6 μM. GSK-3β inhibitor 3 can be used for the research of acute promyelocytic leukemia
In Vitro
GSK-3β inhibitor 3 (compound 4-3) (100 μM) inhibits GSK-3α activity by 87.3%. GSK-3β inhibitor 3 (6.25-100 μM; 24-48 h) dose-dependently inhibits the growth of NB4 and NB4-R1 cells. GSK-3β inhibitor 3 (12.5-100 μM; 24 h) significantly increases the percentage of apoptosis in a dose-dependent pattern in NB4 and NB4-R1 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: NB4 and NB4-R1 cells Concentration: 6.25, 12.5, 25, 50, 100 μM Incubation Time: 24, 48 hours Result: Inhibited the cell viability, with IC 50 s of 19.56 μM and 26.42 μM in NB4 and NB4-R1 cells at 24 h, respectively. Had little cytotoxicity on human normal liver cells (LO 2 ) and human umbilical vein endothelial cells (HUVECs). Apoptosis AnalysisCell Line: NB4 and NB4-R1 cells Concentration: 12.5, 25, 50, 100 μM Incubation Time: 24 hours Result: Induced cell apoptosis.
In Vivo
GSK-3β inhibitor 3 (compound 4-3) (15 mg/kg/d; i.p. for 2 weeks) inhibits tumor growth of mice by 75.97% relative to vehicle control . GSK-3β inhibitor 3 (15 mg/kg; a single i.p.) shows long T 1/2 of 14.2 h, high AUC values (AUC last =3503.42 ng/mL•h), and maximum concentration (C max =515 ng/mL) in mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Balb/c female nude mice were injected leukemia cells Dosage: 15 mg/kg/d Administration: I.p. for 2 weeks Result: Inhibited localized growth in NB4 cells. Had mild weight loss compared with control. Animal Model: Male ICR mice (30 g) Dosage: 15 mg/kg (Pharmacokinetic Analysis) Administration: A single i.p. Result: T 1/2 =14.2 h; AUC last =3503.42 ng/mL•h; C max =515 ng/mL.
IC50& Target:GSK-3β 6.6 μM (IC 50 )
| Peso molecular | 327.37 |
|---|
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →
